RN
Rege Nephro Co
Japan · Biotech · Healthtech
Developing innovative therapies and medical technologies for patients with kidney diseases who currently have limited treatment options
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series C | $10.6M | Arcus South East Asia — Role not disclosedBA7 Venture Capital CORP — Role not disclosedChushin Venture Capital Co — Role not disclosedDCI Partners Co — Role not disclosedJAFCO Group Co — Role not disclosedJIC Venture Growth Investments Co — Role not disclosedKyoshin Social Capital Co — Role not disclosedKyoto University Innovation Capital Co — Role not disclosedMitsubishi UFJ Capital Co — Role not disclosedRAP-HI Co — Role not disclosedSPARX Asset Management Co — Role not disclosedTaiAn Technologies Corp — Role not disclosedTOHO HOLDINGS CO — Role not disclosed |